Pharmacology & ToxicologyJournal of Nuclear MedicinePeer-reviewed
Zr-labeled N4MU01 radioimmunoconjugates as theranostics against nectin-4 positive triple negative breast cancer
Hanan Babeker, Fabrice Ngoh Njotu, Jessica Pougoue Ketchemen…·Humphrey Fonge
This study develops and evaluates Zr-labeled N4MU01 radioimmunoconjugates for imaging and radiotherapy of nectin-4 positive triple-negative breast cancer, showing promising tumor uptake and therapeutic efficacy.